Results 271 to 280 of about 283,427 (308)
Some of the next articles are maybe not open access.
Operational conditions affecting the vaccination of older adults
American Journal of Preventive Medicine, 2004The content and context of the process of vaccinating older adults against influenza in outpatient settings has not been adequately described. Failure to appreciate the causal antecedents or precursors to the act of provider recommendation may explain why so many efficacious interventions identified by the U.S.
John, Fontanesi +8 more
openaire +2 more sources
Young Adults' Use of the Salk Vaccine
Social Problems, 1958By the end of July 1958, three years and three months after the beginning of the national program of vaccinating the population against polio, approximately 50 million adult Americans under 40 years of age had received the full series of three shots; another 20 million had received one or two shots; and a total of 40 million had received no shots at ...
David L. Sills, Rafael E. Gill
openaire +1 more source
The Alarming Inadequacy of Adult Vaccination—Vaccination Rates in Diabetic Patients
Diabetes, 2018Aim: DM is a disease that causes immune incompetence due to various reasons. Therefore, the risk of infectious disease and the risk of complications, morbidity and mortality related to infectious disease in diabetic patients are increased compared to healthy adults.
GÜNEş FEYIZOğLU +2 more
openaire +1 more source
Cost-Effectiveness of the Pneumococcal Vaccine in Healthy Younger Adults
Medical Decision Making, 2002Objectives Routine vaccination for Streptococcus pneumoniae has been recommended as a cost-effective measure for elderly and immunocompromised patients, yet no analysis has been performed for healthy younger adults in America. The authors evaluated the cost-effectiveness of the pneumococcal vaccine and determined the net health benefits conferred for ...
Patricia Vold, Pepper, Douglas K, Owens
openaire +2 more sources
Determining the cost–effectiveness of adult pneumococcal vaccination strategies
Expert Review of Pharmacoeconomics & Outcomes Research, 2013The 23-valent pneumococcal polysaccharide vaccine is known to be economically reasonable in adults. With the 13-valent pneumococcal conjugate vaccine (PCV13) now available, the question is whether 23-valent pneumococcal polysaccharide vaccine offers sufficient protection in adults compared with PCV13.
openaire +2 more sources
The Effect of DHEAS on Influenza Vaccination in Aging Adults
Journal of the American Geriatrics Society, 1997OBJECTIVE : To determine whether simultaneous administration of dehydroepiandrosterone sulfate (DHEAS) exhibits adjuvant activity in the immune response of aging humans by supplementing influenza vaccination with the maximum single dose of DHEAS that could be practically injected subcutaneously (approximately 7 ...
J, Degelau, D, Guay, H, Hallgren
openaire +2 more sources
The Economic Implications of Influenza Vaccination for Adults with Asthma
American Journal of Preventive Medicine, 2010Influenza vaccination is recommended for adults with asthma.This study estimates the effect of influenza vaccination on utilization of medical services and expenditures for acute and chronic respiratory conditions (ACRC) among adults with asthma.The sample was adults aged ≥18 years self-reporting asthma in the 2003 through 2006 Medical Expenditure ...
Justin G, Trogdon +2 more
openaire +2 more sources
VACCINATION OF THE IMMUNOSUPPRESSED ADULT PATIENT WITH RHEUMATOLOGIC DISEASE
Rheumatic Disease Clinics of North America, 1999Vaccine-preventable diseases are a major cause of morbidity in immunocompromised patients. This article reviews the data on efficacy and safety of currently licensed vaccines in patients with rheumatologic diseases.
openaire +2 more sources
The Effectiveness of Vaccination against Influenza in Healthy, Working Adults
New England Journal of Medicine, 1995Although influenza causes substantial morbidity and mortality in all age groups, current recommendations emphasize annual immunization for people at high risk for complications of influenza. We conducted a double-blind, placebo-controlled trial of vaccination against influenza in healthy, working adults.In the fall of 1994, we recruited working adults ...
K L, Nichol +7 more
openaire +2 more sources
Vaccines and autoimmune diseases of the adult.
Discovery medicine, 2010Infectious agents contribute to the environmental factors involved in the development of autoimmune diseases possibly through molecular mimicry mechanisms. Hence, it is feasible that vaccinations may also contribute to the mosaic of autoimmunity. Evidence for the association of vaccinations and the development of these diseases is presented in this ...
Hedi, Orbach +2 more
openaire +1 more source